Plain-English translation of NCT03587922 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Coronary Artery Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is studying a new type of heart stent called the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold. Unlike traditional stents that stay in your artery permanently, this one is designed to dissolve over time once your artery has healed. The study will follow 1,500 patients to make sure this treatment works safely and effectively for opening blocked coronary arteries.
Traditional stents remain in your arteries permanently, which can sometimes cause problems over the long term. This medication was developed to give your artery support while it heals, then gradually dissolve away, potentially reducing future complications and the need for additional procedures.
You likely qualify if…
You likely don't qualify if…
You will undergo a procedure to have the Fantom stent placed into your blocked coronary artery to restore blood flow. After the stent is inserted, you will return for scheduled follow-up visits and imaging tests to monitor how your artery is healing and how the stent is dissolving over time. The study will track your health and any symptoms over an extended period to ensure the treatment is working as intended.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Austria
Germany